Basilea Pharmaceutica AG (OTCMKTS:BPMUF – Get Free Report) hit a new 52-week high during trading on Tuesday . The stock traded as high as $51.26 and last traded at $51.26, with a volume of 165 shares. The stock had previously closed at $51.26.
Basilea Pharmaceutica Stock Performance
The stock’s fifty day moving average is $48.95 and its 200 day moving average is $46.19.
Basilea Pharmaceutica Company Profile
Basilea Pharmaceutica AG, a commercial-stage biopharmaceutical company, focuses on the development of products that address the medical needs in the therapeutic areas of oncology and anti-infectives. The company offers Cresemba, an intravenous and antifungal drug for the treatment of invasive aspergillosis and mucormycosis in the United States, and the European Union.
See Also
- Five stocks we like better than Basilea Pharmaceutica
- Are Penny Stocks a Good Fit for Your Portfolio?
- Galmed Pharmaceuticals Surges 400%: What’s Behind the Explosion?
- How to Start Investing in Real Estate
- Gold Hits New All-Time Highs: 3 Stocks to Ride the Surge
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Intel: Why It’s Time to Reconsider This Beaten-Down Chipmaker
Receive News & Ratings for Basilea Pharmaceutica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Basilea Pharmaceutica and related companies with MarketBeat.com's FREE daily email newsletter.
